Antigens, SurfaceGlutamate Carboxypeptidase IINeoplasm Metastasis
Dr. Jeremie Calais, MD
NPI1053927079
- Publications
- 32
- Clinical trials
- 3
- Industry payments
- $130,660
- State license
- 1
- Year NPI issued
- 2020
- Practice address
- 200 Medical Plz, Los Angeles, CA 90024
- Practice phone
- Call (310) 794-9206
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Peter Morton UCLA Medical Building
Los Angeles, California
Find Dr. Calais' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jeremie Calais is a nuclear imaging and therapy physician in Los Angeles, California
Dr. Calais practices at Peter Morton UCLA Medical Building in Los Angeles, California.
Dr. Calais' NPI, 1053927079, was assigned on September 16, 2020. Dr. Calais graduated from University of Paris VII Faculty of Medicine in 2010. Dr. Calais' California license number on file is SPI645.
NPI and contact details
- NPI
- 1053927079NPI Registry (opens in a new tab)
- NPI enumeration date
- September 16, 2020
- NPI status
- Active
- Practice phone
- (310) 794-9206
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 2010
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Jeremie Calais practices at Peter Morton UCLA Medical Building in Los Angeles, California
Dr. Calais' primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.
- Peter Morton UCLA Medical Building200 Medical Plz, Los Angeles, CA 90024 · Los Angeles CountyPhone(310) 794-9206
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Jeremie Calais is affiliated with 1 site of care
Dr. Calais' primary practice is Peter Morton UCLA Medical Building in Los Angeles, California.
Peter Morton UCLA Medical BuildingPrimary
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Jeremie Calais' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Calais practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Peter Morton UCLA Medical Building | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Calais practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jeremie Calais is one of 20 nuclear imagings and therapy physicians in California
Nuclear imaging and therapy is Dr. Calais' primary specialty in the NPI Registry, under taxonomy code 207UN0902X. Dr. Calais has a license on file in California.
Specialties and state licenses
- Nuclear imaging and therapy, CaliforniaPrimary
Nuclear imagings and therapy physicians near Dr. Calais
Counts of nuclear imagings and therapy physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jeremie Calais' patients have a median age of 66
Across all payers, Dmand AI patient panel data puts Dr. Calais' median patient age at 66, with 0% women.
Dr. Calais' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. Jeremie Calais has 32 publications on record
Dmand AI links 32 papers to Dr. Calais, published from 2021 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Prostate-Specific Antigen, Antigens, Surface and Glutamate Carboxypeptidase II. Dr. Calais has published most often in Eur Urol. Dr. Calais' most frequent co-authors are Johannes Czernin, MD, Matthias Richard Benz, MD and Shadfar Bahri, MD.
Papers32
Years published2021 to 2025
Dr. Calais' papers by year, 2021 to 2025
Topics Dr. Calais writes about most
- Prostate-Specific Antigen
- Antigens, Surface
- Glutamate Carboxypeptidase II
- Prostatic Neoplasms, Castration-Resistant
- Dipeptides
- Heterocyclic Compounds, 1-Ring
- Lutetium
- Molecular Targeted Therapy
Dr. Calais' most frequent co-authors
- Johannes Czernin, MD20 shared papers
- Matthias Richard Benz, MD9 shared papers
- Shadfar Bahri, MD5 shared papers
Recent publications by Dr. Calais
Eur J Nucl Med Mol Imaging
Biological TransportEndopeptidasesMembrane Proteins
See who Dr. Calais researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Calais works with, so you can find a warm path to the right nuclear imagings and therapy physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jeremie Calais has worked on 3 clinical trials
Dmand AI links Dr. Calais to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Jonsson Comprehensive Cancer Center sponsors the most, 3.
Clinical trials with Dr. Calais by phase
- 1Early phase 1: 1 trial
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Calais' trials
- Prostatic Neoplasms
- Prostatic Diseases
Recent clinical trials with Dr. Calais
Prostatic NeoplasmsProstatic DiseasesLutetium Lu 177 Vipivotide Tetraxetan
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy (opens in a new tab)
RecruitingEarly phase 1
Prostatic NeoplasmsProstatic Diseases
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (opens in a new tab)
TerminatedPhase 3
Prostatic NeoplasmsProstatic DiseasesRadiation Therapy
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jeremie Calais received $130,660 in industry payments from 2020 to 2025
CMS Open Payments shows 74 general payments to Dr. Calais from 17 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 76% of the total. Telix Pharmaceuticals paid the most, $41,276. It also lists 6 research payments totaling $17,823 from 2023 to 2025.
General payments to Dr. Calais by program year, 2020 to 2025
General payments to Dr. Calais by kind, 2020 to 2025
$130.7Kin total
- Consulting fees$98,97676%
- Speaker and faculty fees$12,88010%
- Honoraria$10,2508%
- Education$7,0005%
- Other$1,5551%
Companies that paid Dr. Calais the most, 2020 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jeremie Calais graduated from University of Paris VII Faculty of Medicine
Dr. Calais graduated from University of Paris VII Faculty of Medicine in 2010.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jeremie Calais's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jeremie Calais
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jeremie Calais' NPI number?
Dr. Jeremie Calais' NPI number is 1053927079. It was assigned on September 16, 2020, and it is active in the NPI Registry.
What kind of doctor is Dr. Jeremie Calais?
Dr. Jeremie Calais is a nuclear imaging and therapy physician in Los Angeles, California. The primary specialty in the NPI Registry is Nuclear Imaging & Therapy Physician (taxonomy code 207UN0902X).
Where does Dr. Jeremie Calais practice?
Dr. Calais practices at 200 Medical Plz, Los Angeles, CA 90024. Dr. Calais' primary practice is Peter Morton UCLA Medical Building in Los Angeles, California.
What is Dr. Jeremie Calais' office phone number?
The practice phone on file for Dr. Calais is (310) 794-9206.
What is Dr. Jeremie Calais' medical license number?
Dr. Calais' California license number on file is SPI645.
Where did Dr. Jeremie Calais go to medical school?
Dr. Calais graduated from University of Paris VII Faculty of Medicine in 2010.
Has Dr. Jeremie Calais received payments from drug or device companies?
CMS Open Payments shows $130,660 in general payments to Dr. Calais from 17 companies from 2020 to 2025. The largest total came from Telix Pharmaceuticals.
How long has Dr. Jeremie Calais been practicing?
Dr. Calais graduated from medical school in 2010, 16 years ago.
Does Dr. Jeremie Calais do research?
Dmand AI links 32 publications to Dr. Calais, published from 2021 to 2025. Dr. Calais has worked on 3 clinical trials.
Who does Dr. Jeremie Calais publish with?
Dr. Calais' most frequent co-authors are Johannes Czernin, MD (20 shared papers), Matthias Richard Benz, MD (9 shared papers) and Shadfar Bahri, MD (5 shared papers).
Selling to nuclear imaging and therapy practices?
See nuclear imagings and therapy physicians in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card